MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.04, $0.03 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $87 million versus the consensus estimate of $85.12 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.